Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis
Mesenchymal stromal cells (MSCs) are promising candidates for regenerative medicine because of their multipotency, immune-privilege, and paracrine properties including the potential to promote angiogenesis. Accumulating evidence suggests that the inherent properties of cytoprotection and tissue repa...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2016/8737589 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832548885614034944 |
|---|---|
| author | Xiangyang Xia Quanwei Tao Qunchao Ma Huiqiang Chen Jian’an Wang Hong Yu |
| author_facet | Xiangyang Xia Quanwei Tao Qunchao Ma Huiqiang Chen Jian’an Wang Hong Yu |
| author_sort | Xiangyang Xia |
| collection | DOAJ |
| description | Mesenchymal stromal cells (MSCs) are promising candidates for regenerative medicine because of their multipotency, immune-privilege, and paracrine properties including the potential to promote angiogenesis. Accumulating evidence suggests that the inherent properties of cytoprotection and tissue repair by native MSCs can be enhanced by various preconditioning stimuli implemented prior to cell transplantation. Growth hormone-releasing hormone (GHRH), a stimulator in extrahypothalamus systems including tumors, has attracted great attentions in recent years because GHRH and its agonists could promote angiogenesis in various tissues. GHRH and its agonists are proangiogenic in responsive tissues including tumors, and GHRH antagonists have been tested as antitumor agents through their ability to suppress angiogenesis and cell growth. GHRH-R is expressed by MSCs and evolving work from our laboratory indicates that treatment of MSCs with GHRH agonists prior to cell transplantation markedly enhanced the angiogenic potential and tissue reparative properties of MSCs through a STAT3 signaling pathway. In this review we summarized the possible effects of GHRH analogues on cell growth and development, as well as on the proangiogenic properties of MSCs. We also discussed the relationship between GHRH analogues and MSC-mediated angiogenesis. The analyses provide new insights into molecular pathways of MSCs-based therapies and their augmentation by GHRH analogues. |
| format | Article |
| id | doaj-art-5c6a7afd47d14961a3875cd633be8835 |
| institution | Kabale University |
| issn | 1687-966X 1687-9678 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-5c6a7afd47d14961a3875cd633be88352025-02-03T06:12:45ZengWileyStem Cells International1687-966X1687-96782016-01-01201610.1155/2016/87375898737589Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated AngiogenesisXiangyang Xia0Quanwei Tao1Qunchao Ma2Huiqiang Chen3Jian’an Wang4Hong Yu5Department of Ultrasound, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, ChinaHangzhou Leading Pharmatech Co., Ltd., Hangzhou 311100, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, ChinaDepartment of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong 250033, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, ChinaDepartment of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, ChinaMesenchymal stromal cells (MSCs) are promising candidates for regenerative medicine because of their multipotency, immune-privilege, and paracrine properties including the potential to promote angiogenesis. Accumulating evidence suggests that the inherent properties of cytoprotection and tissue repair by native MSCs can be enhanced by various preconditioning stimuli implemented prior to cell transplantation. Growth hormone-releasing hormone (GHRH), a stimulator in extrahypothalamus systems including tumors, has attracted great attentions in recent years because GHRH and its agonists could promote angiogenesis in various tissues. GHRH and its agonists are proangiogenic in responsive tissues including tumors, and GHRH antagonists have been tested as antitumor agents through their ability to suppress angiogenesis and cell growth. GHRH-R is expressed by MSCs and evolving work from our laboratory indicates that treatment of MSCs with GHRH agonists prior to cell transplantation markedly enhanced the angiogenic potential and tissue reparative properties of MSCs through a STAT3 signaling pathway. In this review we summarized the possible effects of GHRH analogues on cell growth and development, as well as on the proangiogenic properties of MSCs. We also discussed the relationship between GHRH analogues and MSC-mediated angiogenesis. The analyses provide new insights into molecular pathways of MSCs-based therapies and their augmentation by GHRH analogues.http://dx.doi.org/10.1155/2016/8737589 |
| spellingShingle | Xiangyang Xia Quanwei Tao Qunchao Ma Huiqiang Chen Jian’an Wang Hong Yu Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis Stem Cells International |
| title | Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis |
| title_full | Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis |
| title_fullStr | Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis |
| title_full_unstemmed | Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis |
| title_short | Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis |
| title_sort | growth hormone releasing hormone and its analogues significance for mscs mediated angiogenesis |
| url | http://dx.doi.org/10.1155/2016/8737589 |
| work_keys_str_mv | AT xiangyangxia growthhormonereleasinghormoneanditsanaloguessignificanceformscsmediatedangiogenesis AT quanweitao growthhormonereleasinghormoneanditsanaloguessignificanceformscsmediatedangiogenesis AT qunchaoma growthhormonereleasinghormoneanditsanaloguessignificanceformscsmediatedangiogenesis AT huiqiangchen growthhormonereleasinghormoneanditsanaloguessignificanceformscsmediatedangiogenesis AT jiananwang growthhormonereleasinghormoneanditsanaloguessignificanceformscsmediatedangiogenesis AT hongyu growthhormonereleasinghormoneanditsanaloguessignificanceformscsmediatedangiogenesis |